Tag Archives: Osi

Cipla not infringing Pfizer patent for drug Tarceva: DHC

In a big relief to pharmaceutical company Cipla Ltd. (“Cipla”), the Delhi High Court ruled that Cipla did not infringe OSI/Pfizer (“Pfizer”) Indian patent for their drug ‘Erlotinib’ (trade name ‘Tarceva’) by manufacture, marketing and sale of their drug ‘Erlocip’, … Continue reading

Posted in Intellectual Property Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment